Assessment of the rs6498486 Polymorphism in the ERCC4 (XPF) Gene and Its Possible Association with Breast Cancer Risk in Bangladeshi Women - Scorecard - MDSpire
Advertisement
Assessment of the rs6498486 Polymorphism in the ERCC4 (XPF) Gene and Its Possible Association with Breast Cancer Risk in Bangladeshi Women
Clinical Scorecard: Assessment of the rs6498486 Polymorphism in the ERCC4 (XPF) Gene and Its Possible Association with Breast Cancer Risk in Bangladeshi Women
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Bangladeshi women diagnosed with breast cancer
Care Setting
Key Highlights
Study involved 150 breast cancer patients and healthy controls.
Guideline-Based Recommendations
Diagnosis
Consider genetic testing for ERCC4 rs6498486 polymorphism in breast cancer risk assessment.
Implement genetic counseling protocols for patients.
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Understanding genetic predisposition may guide personalized treatment approaches, such as targeted therapies.
Clinical Best Practices
Incorporate genetic counseling for patients with family history of breast cancer.
Utilize genetic markers for risk stratification in breast cancer screening programs, including specific testing for ERCC4 variants.
